EBF-37318-08611
3 vaccinations
1 coded response
27 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 212 / MD
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- 3DA-30365-22742
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Moderna
-
2022-06-24
Registered in v-safe
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-09
- 2022-07-14
-
2022-07-21
Dose 2 — Moderna
- 2022-07-22
- 2022-07-23
-
2022-07-24
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: FairFree text: ColdsMedDRA releases: 2024-11 · check-in free text available
- 2022-07-25
- 2022-07-26
- 2022-07-28
- 2022-08-04
- 2022-08-13
- 2022-08-18
- 2022-08-25
- 2022-09-01
-
2022-12-27
Dose 3 — Moderna
- 2023-01-03
- 2023-01-10
- 2023-01-19
- 2023-01-26
- 2023-02-02
- 2023-02-07
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Moderna | No |
| 2 | 2022-07-21 | Moderna | No |
| 3 | 2022-12-27 | Moderna | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release